NVDA vs TRDA · P/E 58, rev $96.22B vs P/E 12, rev $210.8M
NVIDIA Corporation (NVDA) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
NVDA currently screens at market cap $4.40T and trailing P/E 58.2. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the NVDA and TRDA stock pages for the full models.
Not investment advice.